newsfilter
← Latest News
Business Wire·

Ambrx Biopharma Appoints Kate Hermans as Interim CEO, Replacing Feng Tian

- Katrin Rupalla, Ph.D., appointed Chair of Ambrx's Board of Directors - - Ambrx to conduct strategic pipeline review with focus on commercial opportunity and cash runway extension - - Dr. Tian will continue to be available to Ambrx in an advisory